Tanja Stocks

Academic degree

Associate Professor in Epidemiology, Lund University, Sweden, Jan 2018

PhD, Umeå University, Sweden, June 2009. title: Metabolic factors and cancer risk; prospective studies on prostate cancer, colorectal cancer and cancer overall.

BSc in Dietetics, Umeå University, Sweden, 2002

BSc in Sports Pedagogics, Umeå University, Sweden, 2002

Current position

Associate researcher at Lund University, Dept of Clinical Sciences in Malmö, Diabetes and cardiovascular disease - genetic epidemiology. Feb 2014 - present

Previous academic positions

Postdoc. Umeå university, Dept of Surgical and Perioperative Sceinces, Urology and Andrology. Topic: Metabolic risk factors and cancer risk. July 2009 - Jan 2014

Postdoc. Institute of Preventive Medicine, Frederiksberg, Denmark. Topic: Gene-diet interatcitons in obesity. Sept 2010 - April 2013

Postdoc. Amsterdam Free University, Institute of Health Sceinces, Amsterdam, The Netherlands. Topic: Chi8ldhood growth and subsequent obesity. Oct 2009 - July 2010

Research interests

Cancer epidemiology, in particular metabolic and genetic risk factors in relation to risk and prognosis of cancer. Diabetes, obesity and cardiovascular diseases; their determinants and their associations with risk of cancer.

Ongoing projects

Metabolic factors and risk for various cancers in the Metabolic Syndrome and Cancer project (Me-Can) (PI) Me-Can

Mendelian randomization studies of lipids and cancer risk in the Malmö Diet and Cancer Study

Metabolic factors, genetic variants and risk and prognosis of cancers of the prostate and urinary bladder using several Swedish cohorts and national registries.

Ongoing grants

Swedish Cancer Society (2018-2020)

Swedish Research Council (2016-2018)

Nordic Cancer Union (2017)

Crafoord Foundation (2017-2018)

Publications

Fifty-two publications indexed in PubMed, H-factor 24 (Jan 2018).

Selected publications:

Orho-Melander M, Hindy G, Borgquist S, Schulz CA, Manjer J, Melander O, Stocks T. Blood lipid genetic scores, the HMGCR gene, and cancer risk: a Mendelian randomization study. Int J Epidemiol, Nov 2017.

Stocks T, Bjørge T, Ulmer H, Manjer J, Häggström C, Nagel G, Engeland A, Johansen D, Hallmans G, Selmer R, Concin H, Tretli S, Jonsson H, Stattin P. Metabolic risk score and cancer risk: pooled analysis of seven cohorts. Int J Epidemiol, 2015;44(4):1353-63.

Stocks T, Ängquist L, Hager J, Charon C, Holst C, Martinez JA, Saris WH, Astrup A, Sørensen TIA, Larsen LH. TFAP2B-dietary protein and glycemic index interactions and weight maintenance after weight loss in the DiOGenes trial. Hum Hered, 2013;75(2-4):213-9.

Stocks T, Van Hemelrijck M, Manjer J, Bjørge T, Ulmer H, Hallmans G, Lindkvist B, Selmer R, Nagel G, Tretli S, Concin H, Engeland A, Jonsson H, Stattin P. Blood pressure and risk of cancer incidence and mortality in the Metabolic syndrome and Cancer project (Me-Can). Hypertension, 2012;59(4):802-10.

Stocks T, Renders CM, Bulk-Bunschoten AMW, Hirasing RA, van Buuren S, Seidell JC. Body size and growth in 0-4 year old children and the relation to body size in primary school age. Obesity Reviews, 2011;12(8):637-52.

Stocks T, Lukanova A, Bjørge T, Ulmer H, Manjer J, Almquist M, Concin H, Engeland A, Hallmans G, Nagel G, Tretli S, Veierød MB, Jonsson H, Stattin P. Metabolic factors and the risk of colorectal cancer in 580,000 men and women in the metabolic syndrome and cancer project (Me-Can). Cancer, 2011;117(11):2398-407.

Stocks T, Rapp K, Bjørge T, Manjer J, Ulmer H, Selmer R, Lukanova A, Johansen D, Concin H, Tretli S, Hallmans G, Jonsson H, Stattin P. Blood glucose and risk of incident and fatal cancer in the Metabolic syndrome and Cancer project (Me-Can). PLoS Medicine. 2009;6(12):e1000201.